NXP800

NXP800 · Nuvectis Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NXP800, covering 2025-08-08 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma [Phase 1]